Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Intervalo de año de publicación
1.
J Plant Physiol ; 246-247: 153092, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32065919

RESUMEN

The mechanisms regulating, and modulating potato wound-healing processes are of great importance in reducing tuber infections, reducing shrinkage and maintaining quality and nutritional value for growers and consumers. Wound-induced changes in tuber polyamine metabolism have been linked to the modulation of wound healing (WH) and in possibly providing the crucial amount of H2O2 required for suberization processes. In this investigation we determined the effect of inhibition of specific steps within the pathway of polyamine metabolism on polyamine content and the initial accumulation of suberin polyphenolics (SPP) during WH. The accumulation of SPP represents a critical part of the beginning or inchoate phase of tuber WH during closing-layer formation because it serves as a barrier to bacterial infection and is a requisite for the accumulation of suberin polyaliphatics which provide the barrier to fungal infection. Results showed that the inhibitor treatments that caused changes in polyamine content generally did not influence wound-induced accumulation of SPP. Such lack of correlation was found for inhibitors involved in metabolism and oxidation of putrescine (arginine decarboxylase, ornithine decarboxylase, and diamine oxidase). However, accumulation of SPP was dramatically reduced by treatment with guazatine, a potent inhibitor of polyamine oxidase (PAO), and methylglyoxal-bis(guanylhydrazone), a putative inhibitor of S-adenosylmethione decarboxylase which may also cross-react to inhibit PAO. The mode of action of these inhibitors is presumed to be blockage of essential H2O2 production within the WH cell wall. These results are of great importance in understanding the mechanisms modulating WH and ultimately controlling related infections and associated postharvest losses.


Asunto(s)
Diaminas/antagonistas & inhibidores , Lípidos/biosíntesis , Proteínas de Plantas/metabolismo , Tubérculos de la Planta/metabolismo , Poliaminas/antagonistas & inhibidores , Solanum tuberosum/metabolismo , Carboxiliasas/metabolismo , Diaminas/metabolismo , Guanidinas/metabolismo , Mitoguazona/metabolismo , Oxidación-Reducción , Oxidorreductasas actuantes sobre Donantes de Grupo CH-NH/metabolismo , Poliaminas/metabolismo , Putrescina/metabolismo , Solanum tuberosum/enzimología , Poliamino Oxidasa
2.
Bioorg Med Chem Lett ; 18(24): 6352-6, 2008 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-18993068

RESUMEN

A new series of pyrazolo[3,4-d]pyrimidine-3,6-diamines was designed and synthesized as potent and selective inhibitors of the nonreceptor tyrosine kinase, ACK1. These compounds arose from efforts to rigidify an earlier series of N-aryl pyrimidine-5-carboxamides. The synthesis and structure-activity relationships of this new series of inhibitors are reported. The most promising compounds were also profiled for their pharmacokinetic properties.


Asunto(s)
Diaminas/antagonistas & inhibidores , Inhibidores Enzimáticos/síntesis química , Proteínas Tirosina Quinasas/antagonistas & inhibidores , Pirazoles/química , Pirimidinas/química , Animales , Química Farmacéutica/métodos , Cristalografía por Rayos X/métodos , Diseño de Fármacos , Inhibidores Enzimáticos/farmacología , Concentración 50 Inhibidora , Masculino , Modelos Químicos , Conformación Molecular , Proteínas Tirosina Quinasas/química , Ratas , Ratas Sprague-Dawley , Relación Estructura-Actividad
3.
Neurosci Lett ; 142(1): 85-8, 1992 Aug 03.
Artículo en Inglés | MEDLINE | ID: mdl-1407725

RESUMEN

Long chain 1, omega-diamines with 8, 10, 12, 14 and 16 carbon atoms reduced the binding of [3H]MK 801 to rat hippocampal membranes with IC50 values of 333, 72, 16.5, 4.7 and 4.3 microM, respectively. In the presence of medium-effective concentrations of the diamines, the concentration response curve of the stimulation by the polyamine spermine was shifted to higher spermine concentrations, reaching similar maximal stimulation as in the absence of the diamines. In the case of 1,12-diaminododecane (N-12-N) and 1,14-diaminotetradecane (N-14-N), the extent of this shift was compatible with competitive antagonism of spermine. Inhibition of [3H]MK 801 binding by long chain diamines was sensitive to spermine, inhibition by N-12-N and N-14-N exhibited the highest sensitivities. Of all diamines tested, N-12-N and N-14-N seem to be the most likely candidates for inverse polyamine agonists.


Asunto(s)
Diaminas/farmacología , Receptores de N-Metil-D-Aspartato/metabolismo , Aminas/química , Aminas/farmacología , Animales , Diaminas/antagonistas & inhibidores , Diaminas/química , Maleato de Dizocilpina/metabolismo , Relación Dosis-Respuesta a Droga , Concentración Osmolar , Ratas , Ratas Sprague-Dawley , Ratas Wistar , Espermina/farmacología
4.
Clin Exp Immunol ; 72(1): 141-4, 1988 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-3396214

RESUMEN

The consequences of specific inhibition of polyamine biosynthesis by (2R,5R)-6-heptyne-2,5-diamine (MAP) a potent inhibitor of L-ornithine decarboxylase (ODC), on immunoglobulin (Ig) production were studied in cultured human peripheral blood lymphocytes stimulated with pokeweed mitogen (PWM). MAP inhibits the usual PWM-induced increase of polyamine (putrescine, spermidine and spermine) concentrations and reduces concomitantly cell replication. In parallel with these biochemical effects, IgG and IgM production are diminished, a 95% decrease being observed at 100 microM MAP concentration. That the suppressive effects of the ODC inhibitor result from polyamine deficiency, and not from unrelated pharmacological effects, is demonstrated by the restoration of normal Ig production when 10 microM putrescine or spermidine are added to the culture medium. These findings established that the cellular immunological response can be affected by specific inhibition of polyamine biosynthesis and deserve further consideration both under in vitro and in vivo conditions.


Asunto(s)
Diaminas/farmacología , Tolerancia Inmunológica/efectos de los fármacos , Activación de Linfocitos/efectos de los fármacos , Inhibidores de la Ornitina Descarboxilasa , Poliaminas/biosíntesis , Alquinos , Diaminas/antagonistas & inhibidores , Humanos , Inmunoglobulinas/biosíntesis , Linfocitos/inmunología , Linfocitos/metabolismo , Mitógenos de Phytolacca americana/farmacología , Poliaminas/farmacología
5.
Proc Natl Acad Sci U S A ; 79(2): 471-5, 1982 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-6952199

RESUMEN

There are a number of agents which, when added to cultures of murine erythroleukemia cells (MELC), markedly increase the probability of commitment to express the characteristics of terminal erythroid differentiation, including loss of proliferative capacity and increased accumulation of globin mRNA and hemoglobin. Some characteristics of inducer-mediated commitment of MELC to terminal erythroid differentiation were examined by determining the effects of dexamethasone (an inhibitor of inducer-mediated MELC differentiation) and of hemin (an inducer of globin mRNA accumulation). Previously, it was shown that exposure of MELC to hexamethylene-bisacetamide (HMBA) leads to commitment, detectable within 12 hr. MELC cultured with both HMBA and dexamethasone do not express commitment. MELC transferred from culture with HMBA and dexamethasone to cloning medium without these agents express commitment to terminal erythroid differentiation, indicating that MELC retain a "memory" for some early HMBA-mediated changes leading to commitment which occur even in the presence of the inhibitory steroid. The kinetics of commitment in experiments in which exposure to HMBA is interrupted, or dexamethasone is added to the culture in HMBA, suggest that there is a rate-limiting step early in the commitment process. The memory for this step persists for more than one cell cycle. Addition of hemin to cultures with HMBA and dexamethasone initiated accumulation of globin mRNA but does not reverse the steroid-mediated inhibition of terminal cell division (that is, the cells retain their proliferative capacity). Inducer-mediated MELC commitment is associated with accumulation of the chromatin protein IP25; dexamethasone does not inhibit this accumulation. Accumulation of IP25 may be inducer-related, but it is not sufficient to cause expression of terminal erythroid differentiation.


Asunto(s)
Diferenciación Celular/efectos de los fármacos , Eritropoyesis/efectos de los fármacos , Acetamidas/antagonistas & inhibidores , Acetamidas/farmacología , Animales , División Celular/efectos de los fármacos , Línea Celular , Cromatina/metabolismo , Dexametasona/farmacología , Diaminas/antagonistas & inhibidores , Diaminas/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Globinas/genética , Hemina/farmacología , Leucemia Eritroblástica Aguda/patología , Ratones , ARN Mensajero/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA